Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia
Brief Summary
This is a prospective, randomized, single-blind trial evaluating prehospital patients experiencing moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5. Patients will be randomized to receive ketamine at or morphine by intravenous push.
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Recruiting |
| Study results: | No Results Available |
| Age: | 18 Years and older (Adult, Older Adult) |
| Enrollment: | 496 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Nov 23, 2017 | |
|---|---|---|
| Primary Completion: | May 30, 2022 | |
| Completion Date: | May 30, 2022 | |
| Study First Posted: | Aug 02, 2017 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | May 21, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
This study is designed to evaluate if ketamine alone is non inferior to morphine alone for prehospital analgesia. Numeric rating scale pain scores will be compared between recipients of ketamine and recipients of morphine at 15, 30, 45 and 60 min post first injection and at hospital admission.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
This clinical trial is recruiting
Are you interested in participating in this trial or others? We'd love to help.
More Details
| NCT Number: | NCT03236805 |
|---|---|
| Acronym: | KETAMORPH |
| Other IDs: | RC17_0082 |
| Study URL: | https://ClinicalTrials.gov/show/NCT03236805 |
Last updated: Jun 17, 2022